Clinical observation of the intensity modulated radiation therapy concurrent with chemotherapy for recurrent cervical cancer
Wei Feng
Abstract
Wei Feng
Abstract
Objective:To observe the efficacy and toxicities of intensity modulated radiation therapy(IMRT)concurrent with chemotherapy for recurrent cervical cancer.Methods:Fifty four patients with recurrent cervical cancer were dividea into 2 groups:grouped observation group(radiotherapy concurrent with chemotherapy)consisted of 28 patients,receiving IMRT concurrent with chemotherapy of cisplatin and 5-fluorouracil,two cycles at least(cisplatin 20mg/m2 d1-d5,5-Fu 500mg/m2 d1-d5).Control group consisted of 26 patients,treated only with IMRT.All patients received radiotherapy using 6MV-x ray,with 5-7 yields,with total dose of 45-50 GY.Results:The overall response rate was higher in observation group(92.8%)than in control group(76.9%).There was a significant difference in two groups about the total effective rate(P0.05).The frequency of grade Ⅲ acute bone marrow inhibition was 7.1 %,gradeⅢ acute disgusting was 3.6 %,and grade Ⅲ acute diarrhoea was 7.1 %,which could be alleviated.No patient suffered more than grade Ⅲ toxicities in control group.The acute toxicity was significantly different(P0.05)in two groups.There was no significant difference between two groups about the one-year survival rate(P0.05).Conclusion:IMRT concurrent with chemotherapy can improve the early outcome of the recurrent cervical cancer,toxicity of radiation is not increased.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the efficacy and toxicities of intensity modulated radiation therapy(IMRT)concurrent with chemotherapy for recurrent cervical cancer.Methods:Fifty four patients with recurrent cervical cancer were dividea into 2 groups:grouped observation group(radiotherapy concurrent with chemotherapy)consisted of 28 patients,receiving IMRT concurrent with chemotherapy of cisplatin and 5-fluorouracil,two cycles at least(cisplatin 20mg/m2 d1-d5,5-Fu 500mg/m2 d1-d5).Control group consisted of 26 patients,treated only with IMRT.All patients received radiotherapy using 6MV-x ray,with 5-7 yields,with total dose of 45-50 GY.Results:The overall response rate was higher in observation group(92.8%)than in control group(76.9%).There was a significant difference in two groups about the total effective rate(P0.05).The frequency of grade Ⅲ acute bone marrow inhibition was 7.1 %,gradeⅢ acute disgusting was 3.6 %,and grade Ⅲ acute diarrhoea was 7.1 %,which could be alleviated.No patient suffered more than grade Ⅲ toxicities in control group.The acute toxicity was significantly different(P0.05)in two groups.There was no significant difference between two groups about the one-year survival rate(P0.05).Conclusion:IMRT concurrent with chemotherapy can improve the early outcome of the recurrent cervical cancer,toxicity of radiation is not increased.
Key concepts: Medicine, Radiation therapy, Chemotherapy, Cisplatin, Cervical cancer, Bone marrow suppression, Internal medicine, Acute toxicity